Markus Leitinger Mihael V Varosanec Slaven Pikija Romana E Wass Dave Bandke Serge Weis Michael Studnicka Susanne Grinzinger Mark R McCoy Larissa Hauer Johann Sellner
10.3389/fimmu.2018.00108
Front Immunol
2018 Jan 30;9:108.
autoreactive antibodies encephalitis humoral and cellular immune response immune checkpoint inhibitors neurodegeneration neuroinflammation nivolumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/29441072/
Antineoplastic Agents, Immunological / adverse effects Brain Diseases / chemically induced Nivolumab / adverse effects
Antineoplastic Agents, Immunological / adverse effects Brain Diseases / chemically induced Nivolumab / adverse effects Case Reports Review Aged Brain / diagnostic imaging Brain / drug effects Brain / pathology Brain Diseases / diagnostic imaging Brain Diseases / pathology Carcinoma, Non-Small-Cell Lung / diagnostic imaging Carcinoma, Non-Small-Cell Lung / drug therapy Carcinoma, Non-Small-Cell Lung / pathology Fatal Outcome Female Humans Lung Neoplasms / diagnostic imaging Lung Neoplasms / drug therapy Lung Neoplasms / pathology Antineoplastic Agents, Immunological Nivolumab
PMC5797606
29441072
Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature
2018